Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

May 31, 2006

Study Completion Date

March 31, 2007

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DIETARY_SUPPLEMENT

ascorbic acid

DRUG

arsenic trioxide

Trial Locations (4)

Cedars Medical Center, Miami

University of Miami Sylvester Comprehensive Cancer Center, Miami

Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center, Miami Beach

Baptist-South Miami Regional Cancer Program, Miami

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Miami

OTHER

NCT00006021 - Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter